Meningioma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of meningiomas is approximately 7.62 per 100,000 individuals worldwide.<ref name="pmid25872752">{{cite journal| author=Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL| title=Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act. | journal=Cancer | year= 2015 | volume= 121 | issue= 14 | pages= 2400-10 | pmid=25872752 | doi=10.1002/cncr.29379 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25872752 }} </ref> | |||
* The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.<ref name="wiki">Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015</ref> | * The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.<ref name="wiki">Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015</ref> | ||
Revision as of 20:25, 25 September 2015
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Meningioma epidemiology and demographics |
|
Risk calculators and risk factors for Meningioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
The incidence of meningioma is approximately 12 per 100,000 individuals in the united states.[1] The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1] Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[2] Females are more commonly affected with meningiomas than males.[1] Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.[1]
Epidemiology and Demographics
Incidence
- The incidence of meningiomas is approximately 7.62 per 100,000 individuals worldwide.[3]
- The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.[2]
Prevalence
- The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.[1]
- Meningioma is the second most common primary brain tumor worldwide.[4]
- Meningioma accounts for approximately 1 out of 3 primary brain and spinal cord tumors.[5]
- The prevalence of meningioma was estimated to be around 170,000 individuals in the United States.[1]
- Benign meningiomas account for approximately 70% of all meningioma cases.[5]
- Atypical meningiomas account for approximately 15%–25% of all meningioma cases.[5]
- Anaplastic or malignant meningiomas account for about 1%–3% of all meningioma cases.[5]
Age
- Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.[2]
- Meningiomas are uncommon among patients before the age of 40 and should raise suspicion of neurofibromatosis type 2 (NF2) when found among young patients.[6]
Gender
- Females are more commonly affected with meningiomas than males.[1]
- The female to male ratio is approximately 2 to 1.[1]
- The incidence of meningioma among females is approximately 10.22 per 100,000 individuals in the united states.[3]
- The incidence of meningioma among males is approximately 4.85 per 100,000 individuals in the united states.[3]
- The female to male ratio of meningiomas may be inverted among patients who are younger than 15 years of age.[1]
Race
- Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.[1]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 Wiemels J, Wrensch M, Claus EB (2010). "Epidemiology and etiology of meningioma". J Neurooncol. 99 (3): 307–14. doi:10.1007/s11060-010-0386-3. PMC 2945461. PMID 20821343.
- ↑ 2.0 2.1 2.2 Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015
- ↑ 3.0 3.1 3.2 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015). "Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act". Cancer. 121 (14): 2400–10. doi:10.1002/cncr.29379. PMID 25872752.
- ↑ Chamberlain MC, Barnholtz-Sloan JS (2011). "Medical treatment of recurrent meningiomas". Expert Rev Neurother. 11 (10): 1425–32. doi:10.1586/ern.11.38. PMID 21955199.
- ↑ 5.0 5.1 5.2 5.3 Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015
- ↑ Meningeoma. Radiopaedia(2015)http://radiopaedia.org/articles/meningioma Accessed on September, 25th 2015